Roberto Ronca
Impact in
- Immunology top 2%
- Biomarkers in Disease Mechanisms
- Immune cells in cancer
- Immunotherapy and Immune Responses
- Cancer Research top 2%
- Cancer, Hypoxia, and Metabolism
Papers in
-
- Fibroblast Growth Factor Research 25
- Angiogenesis and VEGF in Cancer 14
- Enzyme function and inhibition 14
- Kruppel-like factors research 11
- Immunology 29
- Biomarkers in Disease Mechanisms 17
- Co-authors
- Marco Presta (58 shared papers)Marco Rusnati (10 shared papers)Patrizia Dell’Era (9 shared papers)Stefania Mitola (13 shared papers)Emanuela Moroni (4 shared papers)Arianna Giacomini (40 shared papers)Elisa Apolloni (3 shared papers)Nicholas P. Restifo (3 shared papers)
- Journals
- European Journal of Medicinal Chemistry (7 papers)Journal of Medicinal Chemistry (6 papers)Cancers (6 papers)Blood (5 papers)Oncotarget (5 papers)
- Partner nations
- ItalyUnited StatesUnited Kingdom
In The Last Decade
Roberto Ronca
115 papers receiving 5.2k citations
Roberto Ronca's Hit Papers
Peers
Comparison fields: 5 of 121
- Immunology 1.4k
- Cancer Research 714
- Molecular Biology 2.8k
- Cell Biology 552
- Oncology 820
Countries citing papers authored by Roberto Ronca
This map shows the geographic impact of Roberto Ronca's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberto Ronca with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberto Ronca more than expected).
Fields of papers citing papers by Roberto Ronca
This network shows the impact of papers produced by Roberto Ronca. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberto Ronca. The network helps show where Roberto Ronca may publish in the future.
Co-authors
The 25 scholars most cited alongside Roberto Ronca, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 122 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis Hit paper breakdown → | 2005 | 1062 |
| 2 | 2000 | 450 | |
| 3 | 2017 | 169 | |
| 4 | 2017 | 159 | |
| 5 | 2003 | 155 | |
| 6 | 2009 | 123 | |
| 7 | 2003 | 112 | |
| 8 | 2015 | 104 | |
| 9 | 2005 | 100 | |
| 10 | 2003 | 97 | |
| 11 | Genetic vaccination with "self" tyrosinase-related protein 2 causes melanoma eradication but not vitiligo. | 2000 | 97 |
| 12 | 2018 | 84 | |
| 13 | 2015 | 82 | |
| 14 | 2018 | 74 | |
| 15 | 2016 | 70 | |
| 16 | 2000 | 69 | |
| 17 | 2017 | 69 | |
| 18 | 2012 | 68 | |
| 19 | 2018 | 65 | |
| 20 | 2013 | 64 |
About Roberto Ronca
Roberto Ronca is a scholar working on Molecular Biology, Immunology, Organic Chemistry, Cancer Research and Cell Biology, having authored 122 papers that have together received 5.2k indexed citations. Recurring topics across this work include Fibroblast Growth Factor Research (25 papers), Biomarkers in Disease Mechanisms (17 papers), Angiogenesis and VEGF in Cancer (14 papers), Enzyme function and inhibition (14 papers), Kruppel-like factors research (11 papers), Synthesis and Catalytic Reactions (10 papers), Cancer, Hypoxia, and Metabolism (10 papers) and Proteoglycans and glycosaminoglycans research (9 papers). The work is most often cited by research in Immunology (1.4k citations), Cancer Research (714 citations), Molecular Biology (2.8k citations), Cell Biology (552 citations) and Oncology (820 citations). Roberto Ronca has collaborated with scholars based in Italy, United States and United Kingdom. Frequent co-authors include Marco Presta, Marco Rusnati, Patrizia Dell’Era, Stefania Mitola, Emanuela Moroni, Arianna Giacomini, Elisa Apolloni, Nicholas P. Restifo, P Zamboni and Paola Zanovello. Their work appears in journals such as European Journal of Medicinal Chemistry, Journal of Medicinal Chemistry, Cancers, Blood and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.